Premier Value Calaclear (Chain Drug Consortium)
Welcome to the PulseAid listing for the Premier Value Calaclear drug offered from Chain Drug Consortium. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Chain Drug Consortium |
NON-PROPRIETARY NAME: | Zinc Acetate and Pramoxine Hydrochloride |
SUBSTANCE NAME: | ZINC OXIDE; PRAMOXINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 1998-03-25 |
END MARKETING DATE: | 0000-00-00 |
Premier Value Calaclear HUMAN OTC DRUG Details:
Item Description | Premier Value Calaclear from Chain Drug Consortium |
LABELER NAME: | Chain Drug Consortium |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80; 10(mg/mL; mg/mL) |
START MARKETING DATE: | 1998-03-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68016-400_5c89e3ac-ca4e-ec3a-e053-2a91aa0a1c0b |
PRODUCT NDC: | 68016-400 |
APPLICATION NUMBER: | part347 |
Other ZINC OXIDE; PRAMOXINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: